The rapid drop in her monoclonal component, hematocrit, and serum erythropoietin was followed by the total resolution of both her telangiectasias and leukocytoclastic vasculitis, confirming a dramatic response to plasma cell‐directed therapy (Figure 2). This evidence concerns the gene EPO and telangiectasis.